[go: up one dir, main page]

ES8708235A1 - Un procedimiento para la preparacion de derivados de androstendiona 4-sustituida - Google Patents

Un procedimiento para la preparacion de derivados de androstendiona 4-sustituida

Info

Publication number
ES8708235A1
ES8708235A1 ES557215A ES557215A ES8708235A1 ES 8708235 A1 ES8708235 A1 ES 8708235A1 ES 557215 A ES557215 A ES 557215A ES 557215 A ES557215 A ES 557215A ES 8708235 A1 ES8708235 A1 ES 8708235A1
Authority
ES
Spain
Prior art keywords
preparation
derivatives
androstendione
amino
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES557215A
Other languages
English (en)
Other versions
ES557215A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmitalia Carlo Erba SRL filed Critical Farmitalia Carlo Erba SRL
Publication of ES557215A0 publication Critical patent/ES557215A0/es
Publication of ES8708235A1 publication Critical patent/ES8708235A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0027—Azides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE DERIVADOS DE ANDROSTENDIONA 4-SUSTITUIDA. CONSISTENTE EN REDUCIR UN COMPUESTO DE FORMULA (II) CON PROPANO-1,3-DIETIOL EN TRIETILAMINA, PARA OBTENER EL COMPUESTO DE FORMULA (I). SIENDO: R, GRUPO -NHCOR5, -NHSO2R6, Y OTROS; R5, H, ALCOXI DE C 1 A 3 Y OTROS; R6, COMO R5, EXCEPTO H. POR SU EFECTO INHIBIDOR DE AROMATASA ESTEROIDAL, SE UTILIZAN EN EL TRATAMIENTO DE TUMORES DE HORMONAS AVANZADOS. *FORMULA* M
ES557215A 1985-02-15 1986-11-20 Un procedimiento para la preparacion de derivados de androstendiona 4-sustituida Expired ES8708235A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858503940A GB8503940D0 (en) 1985-02-15 1985-02-15 4-substituted androstendione derivatives

Publications (2)

Publication Number Publication Date
ES557215A0 ES557215A0 (es) 1987-10-01
ES8708235A1 true ES8708235A1 (es) 1987-10-01

Family

ID=10574550

Family Applications (2)

Application Number Title Priority Date Filing Date
ES552052A Expired ES8706165A1 (es) 1985-02-15 1986-02-14 Un procedimiento para la preparacion de derivados de androstendiona 4-sustituida.
ES557215A Expired ES8708235A1 (es) 1985-02-15 1986-11-20 Un procedimiento para la preparacion de derivados de androstendiona 4-sustituida

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES552052A Expired ES8706165A1 (es) 1985-02-15 1986-02-14 Un procedimiento para la preparacion de derivados de androstendiona 4-sustituida.

Country Status (28)

Country Link
US (1) US4757061A (es)
JP (1) JPS61189295A (es)
KR (1) KR930005994B1 (es)
AT (1) AT396239B (es)
AU (1) AU577667B2 (es)
BE (1) BE904226A (es)
CA (1) CA1319362C (es)
CH (1) CH669199A5 (es)
CZ (1) CZ413691A3 (es)
DE (1) DE3604179A1 (es)
DK (1) DK167221B1 (es)
ES (2) ES8706165A1 (es)
FI (1) FI84272C (es)
FR (1) FR2577556B1 (es)
GB (2) GB8503940D0 (es)
GR (1) GR860430B (es)
HK (1) HK94090A (es)
HU (1) HU194909B (es)
IE (1) IE58864B1 (es)
IT (1) IT1190335B (es)
MY (1) MY102038A (es)
NL (1) NL8600383A (es)
NZ (1) NZ215163A (es)
PT (1) PT82030B (es)
SE (2) SE8600668L (es)
SG (1) SG80890G (es)
SU (1) SU1574178A3 (es)
ZA (1) ZA861118B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8622330D0 (en) * 1986-09-17 1986-10-22 Erba Farmitalia 4-substituted 6-alkylidenandrostene-3,17-dione derivatives
GB8624251D0 (en) * 1986-10-09 1986-11-12 Erba Farmitalia "1,2-beta-methylene-4-substituted androstene-3,17 dione derivatives
DE3711772A1 (de) * 1987-04-08 1988-10-27 Schering Ag 4- und 15-disubstituierte 4-androsten-3,17-dione und verfahren zu deren herstellung
GB8711579D0 (en) * 1987-05-15 1987-06-17 Erba Farmitalia 4-amino-androstenedione derivatives
US5595985A (en) 1989-03-10 1997-01-21 Endorecherche Inc. Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia
ES2222633T3 (es) * 1989-07-07 2005-02-01 Endorecherche Inc. Terapia combinada para la profilaxis y/o el tratamiento de la hiperplasia prostatica benigna.
US5130424A (en) * 1990-08-01 1992-07-14 Merrell Dow Pharmaceuticals Inc. 4-amino-delta-4,6-steroids and their use as 5 alpha-reductase inhibitors
US5120840A (en) * 1990-08-01 1992-06-09 Merrell Dow Pharmaceuticals Inc. 4-amino-4-ene-steroids and their use as 5α-reductase inhibitors
US5218110A (en) * 1990-08-01 1993-06-08 Merrell Dow Pharmaceuticals 4-amino-Δ4 -steroids and their use as 5α-reductase inhibitors
NZ239142A (en) * 1990-08-01 1994-05-26 Merrell Dow Pharma 4-amino-delta-4-steroids; preparatory processes and pharmaceutical compositions
US5318961A (en) * 1990-08-01 1994-06-07 Merrell Dow Pharmaceuticals Inc. 4-amino-Δ4-steroids and their use as 5α-reductase inhibitors
US5143909A (en) * 1991-03-19 1992-09-01 Merrell Dow Pharmaceuticals Inc. Aminosteroids in a method for inhibiting c17-20 lyase
AU642757B2 (en) * 1990-08-01 1993-10-28 Merrell Dow Pharmaceuticals Inc. 4-amino-delta4, 6-steroids and their use as 5alpha-reductase inhibitors
US5162337A (en) * 1990-10-05 1992-11-10 Merck & Co., Inc. Animal growth promotion
US5189032A (en) * 1991-03-19 1993-02-23 Merrell Dow Pharmaceuticals Inc. 4-amino-Δ4,6 -steroids and their use as 5α-reductase inhibitors
EP0582713B1 (en) * 1991-03-28 1997-06-04 Teikoku Hormone Mfg. Co., Ltd. -New D-homo-17-oxa and D-homo-17-aza-androstane derivatives
CH683151A5 (de) * 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
GB9111260D0 (en) * 1991-05-24 1991-07-17 Erba Carlo Spa Process for the preparation of 4-amino-unsaturated androstanedione derivatives
GB9217035D0 (en) * 1992-08-11 1992-09-23 Erba Carlo Spa Androst-4-eno(4,5-b)pyrrole derivatives and process for their preparation
US5539127A (en) * 1992-09-30 1996-07-23 Teikoku Hormone Mfg. Co., Ltd. 7-substituted oxa- or azasteroid compound
HUT68320A (en) * 1993-02-18 1995-06-28 Erba Farmitalia Fluorinated 4-amino-androstadiene-derivatives, pharmaceutical composition containing the same and process for producing them
US5486511A (en) * 1993-05-25 1996-01-23 Merrell Dow Pharmaceuticals Inc. 4-amino-17β-(cyclopropyloxy)androst-4-en-3-one, 4-amino-17β-(cyclopropylamino)androst-4-en-3-one and related compounds as C17-20 lyase and 5α-reductase
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
GB2284605A (en) * 1993-12-09 1995-06-14 Erba Carlo Spa 6-or 7-substituted 4-aminoandrostadienone derivatives
CA2188760A1 (en) * 1994-05-02 1995-11-09 Philip M. Weintraub Process for the preparation of 4-amino-3-ketosteroids via 4-nitro-4-3-ketosteroids
US6365597B1 (en) 1996-02-14 2002-04-02 Aventis Pharmaceuticals Inc. 4-aza steroids
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US7435757B2 (en) * 2004-07-02 2008-10-14 Schering Ag 2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1042291A (en) * 1961-11-08 1966-09-14 Organon Labor Ltd í¸-6ª‡-amino steroids and the preparation thereof
DE1203768B (de) * 1962-02-01 1965-10-28 Merck Ag E Verfahren zur Herstellung von N-substituierten 4-Aminosteroiden der Testosteronreiheund Saeureadditionssalzen derselben
DK120154B (da) * 1968-02-29 1971-04-19 Schering Ag Fremgangsmåde til fremstilling af N-substituerede 4-amino-3-oxosteroid-4,6-diener af androstan- eller pregnanrækken eller deres ammoniumsalte.
DE1668690C3 (de) * 1968-02-29 1978-09-14 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von N-substituierten 4-Aminosteroiden der Androstan-Pregnan- und Cholestanreihe
US3780070A (en) * 1972-09-21 1973-12-18 Schering Corp 4-azido-17alpha-alkinyl-4-gonen-17beta-ol-3-ones and method for their preparation
CA1154008A (en) * 1979-05-02 1983-09-20 Thomas R. Blohm STEROID 5.alpha.-REDUCTASE INHIBITORS

Also Published As

Publication number Publication date
IE860413L (en) 1986-08-15
US4757061A (en) 1988-07-12
IE58864B1 (en) 1993-11-17
GB2171100B (en) 1988-11-30
DK71486D0 (da) 1986-02-14
CZ413691A3 (en) 1994-03-16
FR2577556B1 (fr) 1988-01-08
PT82030B (pt) 1988-07-01
AT396239B (de) 1993-07-26
IT1190335B (it) 1988-02-16
SG80890G (en) 1990-11-23
ZA861118B (en) 1986-10-29
SE8600668D0 (sv) 1986-02-14
SU1574178A3 (ru) 1990-06-23
IT8619361A0 (it) 1986-02-11
KR860006485A (ko) 1986-09-11
AU5343386A (en) 1986-08-21
FI860672A0 (fi) 1986-02-13
ES557215A0 (es) 1987-10-01
GB2171100A (en) 1986-08-20
ES8706165A1 (es) 1987-06-01
KR930005994B1 (ko) 1993-07-01
FI860672A7 (fi) 1986-08-16
GR860430B (en) 1986-06-12
AU577667B2 (en) 1988-09-29
PT82030A (en) 1986-03-01
IT8619361A1 (it) 1987-08-11
GB8603265D0 (en) 1986-03-19
SE468515B (sv) 1993-02-01
FI84272C (fi) 1991-11-11
GB8503940D0 (en) 1985-03-20
CH669199A5 (de) 1989-02-28
DE3604179A1 (de) 1986-08-21
HUT40454A (en) 1986-12-28
ES552052A0 (es) 1987-06-01
BE904226A (fr) 1986-08-14
ATA38886A (de) 1992-11-15
HU194909B (en) 1988-03-28
JPH0469638B2 (es) 1992-11-06
DK167221B1 (da) 1993-09-20
DK71486A (da) 1986-08-16
FR2577556A1 (fr) 1986-08-22
JPS61189295A (ja) 1986-08-22
MY102038A (en) 1992-02-29
HK94090A (en) 1990-11-23
NL8600383A (nl) 1986-09-01
NZ215163A (en) 1988-02-29
FI84272B (fi) 1991-07-31
SE8600668L (sv) 1986-08-16
CA1319362C (en) 1993-06-22

Similar Documents

Publication Publication Date Title
ES8708235A1 (es) Un procedimiento para la preparacion de derivados de androstendiona 4-sustituida
GEP19981274B (en) Urinary follicle stimulating hormone, pharmaceutical composition, component of pharmaceutical composition
BG50278A3 (bg) Метод за получаване на (1н-азол-1-илметил)-заместени бензотриазолови производни
ES532789A0 (es) Procedimiento para el tratamiento de napas no-tejidas
IT1205849B (it) Derivati di indolo,procedimenti per prepararli e composizioni farmaceutiche che li contengono per il trattamento di emicrania
NO873243L (no) Legemiddel med antitumorvirkning.
ES2039278T3 (es) Procedimiento para preparar inhibidores de 5-alfa-reductasa de esteroides.
ES8606336A1 (es) Un procedimiento para la preparacion de derivados de tiazol 2,4-disustituidos
FI886019A7 (fi) Laastari vaikuttavien aineiden valvotusti jakamiseksi iholle
PT67164A (en) Process for the preparation of hydantoin derivatives as therapeutic agents
FI874189L (fi) Epimeerisen jakaantumisen säätelymenetelmä pregnaanijohdannaisten 16,17-asetaalien valmistuksessa
AU2315288A (en) Cell growth inhibitors and methods of treating cancer and cell proliferative diseases
ATE78481T1 (de) Stoff, stoffzusammensetzung und deren anwendungsverfahren.
MY100900A (en) Substituted phenylsulfonyloxybenzimidazolecarbamates, processes for their preparation and their use as medicaments.
ES2002083A6 (es) Un metodo para preparar derivados de piroglutamida
AR240926A2 (es) "procedimiento para la preparacion de 8-isopropil-6-dimetilamino metil-7-hidroxi-4-metil-cumarina".
MX3743E (es) Procedimiento para la preparacion de derivados 3,4-dihidro-2 (lh)-quinazolinona
IT1216772B (it) Derivati di indolo ,procedimento per prepararli e composizioni farmaceutiche che li contengono per il trattamento di emicrania
BG47648A3 (en) Method for preparing of triazolyl quanolinic compounds
MX148557A (es) Mejoras en metodo para el tratamiento de la madera
ES2004218A6 (es) Procedimiento para preparar derivados de purina
ES554903A0 (es) Disposicion para el tratamiento de piezas de trabajo
ES8502435A1 (es) Un metodo para preparar 2(1h)-piridinonas
BG44203A3 (en) Method for preparing of 2- oxyindol- 1- carboxamides
JPS5246098A (en) Method of preparing cytidine derivatives

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519